Hongmiao Liu1, Weifeng Zhou1, Hui Liao1, Zhengyang Hu1, Min Zou1, Shuwen Liu1. 1. School of Pharmaceutical Sciences, Guangdong Provincial Key Lab of Drug Screening, Guangzhou Key Lab of Drug Research for Emerging Virus Prevention and Treatment, Guangzhou 510515, China.
Abstract
OBJECTIVE: To establish a non-coated enzyme-linked immunosorbent assay (ELISA) based on zika virus envelope (E) protein for detecting the expression of E protein in infected cells. METHODS: Adherent Vero-143 cells infected with zika virus in a 96-well plate were fixed, and the antibodies against zika virus E protein were added at an optimized concentration to establish the non-coated ELISA method for E protein. The antiviral activities of lignans compound C1 was evaluated using this method. The accuracy of this non-coated ELISA was verified by RT-PCR, and the cross reaction with dengue virus was assessed. RESULTS: After optimization, the background absorbance at 450 nm of uninfected cells was reduced to about 0.20. The antiviral activities of lignans compound C1 detected by this method were basically consistent with the results of RT-PCR. No cross reaction with dengue virus was found in this assay. CONCLUSIONS: A non- coated ELISA method based on zika virus E protein was established, which can be used for screening antiviral agents against zika virus.
OBJECTIVE: To establish a non-coated enzyme-linked immunosorbent assay (ELISA) based on zika virus envelope (E) protein for detecting the expression of E protein in infected cells. METHODS: Adherent Vero-143 cells infected with zika virus in a 96-well plate were fixed, and the antibodies against zika virus E protein were added at an optimized concentration to establish the non-coated ELISA method for E protein. The antiviral activities of lignans compound C1 was evaluated using this method. The accuracy of this non-coated ELISA was verified by RT-PCR, and the cross reaction with dengue virus was assessed. RESULTS: After optimization, the background absorbance at 450 nm of uninfected cells was reduced to about 0.20. The antiviral activities of lignans compound C1 detected by this method were basically consistent with the results of RT-PCR. No cross reaction with dengue virus was found in this assay. CONCLUSIONS: A non- coated ELISA method based on zika virus E protein was established, which can be used for screening antiviral agents against zika virus.
Authors: Mohammad R Karim; G Shay Fout; Clifford H Johnson; Karen M White; Sandhya U Parshionikar Journal: J Virol Methods Date: 2015-03-18 Impact factor: 2.014
Authors: Nicholas J Barrows; Rafael K Campos; Steven T Powell; K Reddisiva Prasanth; Geraldine Schott-Lerner; Ruben Soto-Acosta; Gaddiel Galarza-Muñoz; Erica L McGrath; Rheanna Urrabaz-Garza; Junling Gao; Ping Wu; Ramkumar Menon; George Saade; Ildefonso Fernandez-Salas; Shannan L Rossi; Nikos Vasilakis; Andrew Routh; Shelton S Bradrick; Mariano A Garcia-Blanco Journal: Cell Host Microbe Date: 2016-07-28 Impact factor: 21.023
Authors: Michelle N D Balm; Chun Kiat Lee; Hong Kai Lee; Lily Chiu; Evelyn S C Koay; Julian W Tang Journal: J Med Virol Date: 2012-09 Impact factor: 2.327
Authors: Katja Steinhagen; Christian Probst; Christiane Radzimski; Jonas Schmidt-Chanasit; Petra Emmerich; Marjan van Esbroeck; Janke Schinkel; Martin P Grobusch; Abraham Goorhuis; Jens M Warnecke; Erik Lattwein; Lars Komorowski; Andrea Deerberg; Sandra Saschenbrecker; Winfried Stöcker; Wolfgang Schlumberger Journal: Euro Surveill Date: 2016-12-15
Authors: Mariana Kikuti; Laura B Tauro; Patrícia S S Moreira; Gúbio S Campos; Igor A D Paploski; Scott C Weaver; Mitermayer G Reis; Uriel Kitron; Guilherme S Ribeiro Journal: Virol J Date: 2018-07-13 Impact factor: 4.099